Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen trometamol injection for patent ductus arteriosus in premature neonates
ChiCTR2100052063Phase 3Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by West China Second University Hospital. Primary endpoints: Closure rate of ductus arteriosus in all neonates, Proportion of neonates receiving the second course of treatment and 1 more. Started Jan 2021; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on ChiCTR2100052063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052063.